| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/17/2023 | 10.5% | Barclays | $19 → $18 | Maintains | Overweight |
| 09/15/2023 | 16.64% | Mizuho | → $19 | Reiterates | Buy → Buy |
| 08/29/2023 | 16.64% | Mizuho | → $19 | Reiterates | Buy → Buy |
| 08/23/2023 | -14.06% | Morgan Stanley | $15 → $14 | Maintains | Equal-Weight |
| 08/23/2023 | 16.64% | Barclays | → $19 | Initiates Coverage On | → Overweight |
| 08/07/2023 | 28.91% | UBS | $19 → $21 | Upgrades | Neutral → Buy |
| 07/21/2023 | -7.92% | Morgan Stanley | $15 → $15 | Reiterates | Equal-Weight → Equal-Weight |
| 07/07/2023 | 28.91% | Guggenheim | $22 → $21 | Maintains | Buy |
| 06/23/2023 | -7.92% | Morgan Stanley | $15 → $15 | Reiterates | Equal-Weight → Equal-Weight |
| 06/01/2023 | 10.5% | UBS | $19 → $18 | Maintains | Neutral |
| 05/30/2023 | 28.91% | RBC Capital | $20 → $21 | Maintains | Outperform |
| 05/22/2023 | -7.92% | Morgan Stanley | $16 → $15 | Maintains | Equal-Weight |
| 04/26/2023 | -1.78% | Morgan Stanley | $15 → $16 | Maintains | Equal-Weight |
| 04/20/2023 | -7.92% | Morgan Stanley | $13 → $15 | Maintains | Equal-Weight |
| 04/03/2023 | 25.84% | Ladenburg Thalmann | → $20.5 | Initiates Coverage On | → Buy |
| 03/10/2023 | 22.77% | RBC Capital | → $20 | Reiterates | → Outperform |
| 02/24/2023 | 16.64% | Credit Suisse | $18 → $19 | Maintains | Outperform |
| 02/22/2023 | -14.06% | Morgan Stanley | $15 → $14 | Maintains | Equal-Weight |
| 01/03/2023 | 4.36% | UBS | → $17 | Downgrades | Buy → Neutral |
| 11/11/2022 | -14.06% | Morgan Stanley | $12.5 → $14 | Maintains | Equal-Weight |
| 10/28/2022 | 4.36% | Credit Suisse | $16 → $17 | Maintains | Outperform |
| 10/28/2022 | 10.5% | Wells Fargo | $17 → $18 | Maintains | Overweight |
| 10/21/2022 | -23.27% | Morgan Stanley | $14 → $12.5 | Maintains | Equal-Weight |
| 10/19/2022 | 4.36% | Wells Fargo | $19 → $17 | Maintains | Overweight |
| 10/07/2022 | 16.64% | RBC Capital | $16 → $19 | Maintains | Outperform |
| 09/29/2022 | -1.78% | Credit Suisse | $15 → $16 | Maintains | Outperform |
| 08/23/2022 | -14.06% | Morgan Stanley | $13 → $14 | Maintains | Equal-Weight |
| 07/21/2022 | -20.2% | Morgan Stanley | $11.5 → $13 | Maintains | Equal-Weight |
| 07/18/2022 | -1.78% | Barclays | $17 → $16 | Maintains | Overweight |
| 07/14/2022 | -7.92% | Credit Suisse | $17 → $15 | Maintains | Outperform |
| 05/23/2022 | -17.13% | Morgan Stanley | $14 → $13.5 | Maintains | Equal-Weight |
| 04/29/2022 | 16.64% | Wells Fargo | $18 → $19 | Maintains | Overweight |
| 04/26/2022 | 4.36% | Credit Suisse | → $17 | Initiates Coverage On | → Outperform |
| 04/20/2022 | -14.06% | Morgan Stanley | $13 → $14 | Maintains | Equal-Weight |
| 03/22/2022 | -20.2% | Morgan Stanley | $12 → $13 | Maintains | Equal-Weight |
| 01/28/2022 | 7.43% | Mizuho | $16 → $17.5 | Maintains | Buy |
| 01/06/2022 | -20.2% | Morgan Stanley | $11.5 → $13 | Maintains | Equal-Weight |
| 12/21/2021 | -29.4% | Morgan Stanley | $10.5 → $11.5 | Maintains | Equal-Weight |
| 09/17/2021 | -38.61% | Morgan Stanley | $10.5 → $10 | Maintains | Equal-Weight |
| 09/09/2021 | -35.54% | Morgan Stanley | $14 → $10.5 | Maintains | Equal-Weight |
| 08/16/2021 | -14.06% | RBC Capital | → $14 | Upgrades | Sector Perform → Outperform |
| 05/03/2021 | -4.85% | Wells Fargo | $12 → $15.5 | Upgrades | Equal-Weight → Overweight |
| 04/20/2021 | -14.06% | Morgan Stanley | $13 → $14 | Maintains | Equal-Weight |
| 03/04/2021 | -26.34% | Wells Fargo | → $12 | Upgrades | Underweight → Equal-Weight |
| 01/20/2021 | -20.2% | Morgan Stanley | $13.5 → $13 | Maintains | Equal-Weight |
| 01/06/2021 | -20.2% | Wells Fargo | → $13 | Downgrades | Equal-Weight → Underweight |
| 12/15/2020 | -17.13% | Morgan Stanley | $14.5 → $13.5 | Maintains | Equal-Weight |
| 11/17/2020 | -10.99% | Morgan Stanley | $14 → $14.5 | Maintains | Equal-Weight |
| 11/12/2020 | — | Wolfe Research | Upgrades | Peer Perform → Outperform | |
| 10/20/2020 | -14.06% | Morgan Stanley | $13 → $14 | Maintains | Equal-Weight |
| 10/05/2020 | -20.2% | Morgan Stanley | $13.5 → $13 | Maintains | Equal-Weight |
| 09/18/2020 | -17.13% | Morgan Stanley | $13 → $13.5 | Maintains | Equal-Weight |
| 08/14/2020 | -20.2% | Morgan Stanley | $12 → $13 | Maintains | Equal-Weight |
| 08/03/2020 | -10.99% | Mizuho | $13.5 → $14.5 | Maintains | Buy |
| 07/17/2020 | -26.34% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight |
| 06/29/2020 | -32.47% | Morgan Stanley | $13 → $11 | Maintains | Equal-Weight |
| 06/23/2020 | — | Seaport Global | Initiates Coverage On | → Neutral | |
| 06/17/2020 | -20.2% | Morgan Stanley | $10 → $13 | Maintains | Equal-Weight |
| 06/05/2020 | -14.06% | B of A Securities | → $14 | Reinstates | → Buy |
| 05/15/2020 | -7.92% | Barclays | → $15 | Upgrades | Equal-Weight → Overweight |
| 05/06/2020 | -17.13% | Mizuho | $12.5 → $13.5 | Maintains | Buy |
| 05/04/2020 | -26.34% | Wells Fargo | $11 → $12 | Maintains | Equal-Weight |
| 05/04/2020 | — | UBS | Upgrades | Neutral → Buy | |
| 04/16/2020 | -14.06% | UBS | $18 → $14 | Maintains | Neutral |
| 04/07/2020 | -23.27% | Mizuho | $15.5 → $12.5 | Maintains | Buy |
| 03/31/2020 | -38.61% | Morgan Stanley | $16 → $10 | Maintains | Equal-Weight |
| 03/26/2020 | -44.75% | Barclays | $15 → $9 | Maintains | Equal-Weight |
| 03/03/2020 | 22.77% | Mizuho | $24.5 → $20 | Maintains | Buy |
| 01/28/2020 | -1.78% | Barclays | $10 → $16 | Maintains | Equal-Weight |
| 01/28/2020 | 35.05% | Mizuho | $21 → $22 | Upgrades | Neutral → Buy |
| 01/24/2020 | -7.92% | UBS | $9 → $15 | Maintains | Neutral |
| 01/15/2020 | -7.92% | Citigroup | $11 → $15 | Upgrades | Neutral → Buy |
| 12/18/2019 | -32.47% | Citigroup | → $11 | Upgrades | Sell → Neutral |
| 12/11/2019 | -35.54% | Citigroup | $5 → $10.5 | Maintains | Sell |
| 11/25/2019 | -44.75% | UBS | $10 → $9 | Maintains | Neutral |
| 10/11/2019 | -38.61% | UBS | $13 → $10 | Maintains | Neutral |
| 10/09/2019 | -1.78% | Morgan Stanley | $23 → $16 | Maintains | Equal-Weight |
| 10/01/2019 | -38.61% | Barclays | $14 → $10 | Maintains | Equal-Weight |
| 09/16/2019 | -26.34% | Citigroup | $4 → $12 | Upgrades | Sell → Neutral |
| 08/20/2019 | -20.2% | UBS | $24 → $13 | Maintains | Neutral |
| 08/19/2019 | -75.45% | Citigroup | $33 → $4 | Downgrades | Buy → Sell |
| 07/15/2019 | 41.19% | Morgan Stanley | $17.5 → $23 | Maintains | Equal-Weight |
| 06/28/2019 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
| 02/26/2019 | — | Argus Research | Upgrades | Sell → Hold | |
| 02/19/2019 | 102.58% | Citigroup | $11 → $33 | Upgrades | Neutral → Buy |
| 01/28/2019 | — | Wolfe Research | Upgrades | Peer Perform → Outperform | |
| 01/25/2019 | 7.43% | Morgan Stanley | $13 → $17.5 | Maintains | Equal-Weight |
| 01/25/2019 | -32.47% | JP Morgan | $10 → $11 | Maintains | Neutral |
| 01/16/2019 | -38.61% | Wells Fargo | $15 → $10 | Downgrades | Outperform → Market Perform |
| 01/15/2019 | -20.2% | Morgan Stanley | $31 → $13 | Maintains | Equal-Weight |
| 01/15/2019 | — | Argus Research | Downgrades | Buy → Sell | |
| 01/15/2019 | — | Macquarie | Downgrades | Outperform → Neutral | |
| 01/14/2019 | — | B of A Securities | Terminates Coverage On | Buy → Buy | |
| 01/14/2019 | 35.05% | JP Morgan | $39 → $22 | Downgrades | Overweight → Neutral |
| 01/09/2019 | 35.05% | B of A Securities | $44 → $22 | Maintains | Buy |
| 01/08/2019 | 16.64% | Mizuho | $27 → $19 | Maintains | Neutral |
| 01/07/2019 | 78.02% | UBS | $26 → $29 | Maintains | Neutral |
| 11/19/2018 | 84.16% | Barclays | $53 → $30 | Maintains | Equal-Weight |
| 11/19/2018 | 145.55% | Citigroup | $48 → $40 | Upgrades | Neutral → Buy |
| 11/16/2018 | 120.99% | Argus Research | $54 → $36 | Maintains | Buy |
| 11/16/2018 | — | Citigroup | Upgrades | Neutral → Buy | |
| 11/16/2018 | 90.3% | Morgan Stanley | $67 → $31 | Downgrades | Overweight → Equal-Weight |
| 11/15/2018 | 90.3% | Morgan Stanley | $67 → $31 | Downgrades | Overweight → Equal-Weight |
| 11/14/2018 | — | Edward Jones | Downgrades | Hold → Sell |
What is the target price for PG&E (PCG)?
The latest price target for PG&E (NYSE: PCG) was reported by Barclays on October 17, 2023. The analyst firm set a price target for $18.00 expecting PCG to rise to within 12 months (a possible 10.50% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for PG&E (PCG)?
The latest analyst rating for PG&E (NYSE: PCG) was provided by Barclays, and PG&E maintained their overweight rating.
When is the next analyst rating going to be posted or updated for PG&E (PCG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PG&E, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PG&E was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
Is the Analyst Rating PG&E (PCG) correct?
While ratings are subjective and will change, the latest PG&E (PCG) rating was a maintained with a price target of $19.00 to $18.00. The current price PG&E (PCG) is trading at is $16.29, which is out of the analyst's predicted range.